Bayesian Capital Management’s Halozyme HALO Stock Holding History
Bought
Maintained
Sold
Other funds holding HALO
VCM
VPM
Bayesian Capital Management's HALO Position: Q1 2026 in Review
Bayesian Capital Management sold out of Halozyme (HALO) in Q1 2026, closing a stake of 4,804 shares — an estimated $323K sold.
Bayesian Capital Management first reported a position in HALO in Q2 2016 and held it in 15 quarters. The position peaked at $2.53M in Q3 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.
- Bayesian Capital Management reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
- Bayesian Capital Management sold 4,804 Halozyme shares in Q1 2026, an estimated $323K.
- Bayesian Capital Management first reported a position in Halozyme in Q2 2016 and held it in 15 quarters.
- Bayesian Capital Management's Halozyme position peaked at $2.53M in Q3 2025.
- 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.
Based on Bayesian Capital Management's 13F filing for Q1 2026, filed 15 May 2026.